UMB Bank’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,379
Closed -$10.4K – 2173
2024
Q1
$10.4K Hold
1,379
– – ﹤0.01% 1274
2023
Q4
$12.8K Hold
1,379
– – ﹤0.01% 1209
2023
Q3
$14K Hold
1,379
– – ﹤0.01% 1180
2023
Q2
$17.2K Hold
1,379
– – ﹤0.01% 1121
2023
Q1
$16.1K Hold
1,379
– – ﹤0.01% 1150
2022
Q4
$15K Buy
+1,379
New +$13.3K ﹤0.01% 1184
2022
Q1
– Sell
-750
Closed -$30K – 2013
2021
Q4
$30K Buy
+750
New +$34.2K ﹤0.01% 1143

Other funds holding HCAT

UMB Bank's HCAT Position: Q2 2024 in Review

UMB Bank sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 1,379 shares — an estimated $10.4K sold.

UMB Bank first reported a position in HCAT in Q4 2021 and held it in 7 quarters. The position peaked at $30K in Q4 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • UMB Bank reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • UMB Bank sold 1,379 Health Catalyst shares in Q2 2024, an estimated $10.4K.
  • UMB Bank first reported a position in Health Catalyst in Q4 2021 and held it in 7 quarters.
  • UMB Bank's Health Catalyst position peaked at $30K in Q4 2021.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on UMB Bank's 13F filing for Q2 2024, filed 29 Jul 2024.